OREM, UT, January 14, 2014 /24-7PressRelease/
-- Providers report that despite vendor efforts, CDS reference products are still not integrated enough to deliver the strategic direction providers are looking for. This and other findings are revealed in the latest KLAS report, entitled Clinical Decision Support 2013: Sizing Up Point-of-Care Reference Tools.
"Providers acknowledged the impact the tools are having and the efforts some vendors are making to leverage strategic partnerships but declared that most products offered are still too much in silos," said report author Adam Cherrington. "Providers were very quick to mention the efforts of EBSCO, Elsevier, Wolters Kluwer, Truven Health Analytics and others to align with their needs, but even though providers appreciated the high performance of most solutions, they felt that more portfolio integration would result in even greater impacts on patient care."
The report focused on four groups of CDS tools: disease reference, drug reference, nursing reference and diagnostic decision support. As part of the report, KLAS interviewed providers about the impact of these tools on patient care, usability, perceived value and workflow.
For further details, visit KLAS online at www.KLASresearch.com/reports
and view Clinical Decision Support 2013: Sizing Up Point-of-Care Reference Tools
. The report is available to healthcare providers and vendors. Providers receive a significant discount off the standard retail price or can receive a complimentary summary report in exchange for a survey about one of their current vendors.
KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and counted. Working with thousands of healthcare professionals and clinicians, KLAS gathers data on software, services, medical equipment and infrastructure systems to deliver timely reports, trends and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving vendor performance. Follow KLAS on Twitter at www.twitter.com/KLASresearch